CELEX: 62016TA0362
Language: en
Date: 2018-06-19 00:00:00
Title: Case T-362/16: Judgment of the General Court of 19 June 2018 — Tillotts Pharma v EUIPO — Ferring (XENASA) (EU trade mark — Opposition proceedings — Application for EU word mark XENASA — Earlier EU word mark PENTASA — Relative ground for refusal — No likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001))

201807130542004272018/C 268/383622016TC26820180730EN01ENINFO_JUDICIAL20180619323211Case T-362/16: Judgment of the General Court of 19 June 2018 — Tillotts Pharma v EUIPO — Ferring (XENASA) (EU trade mark — Opposition proceedings — Application for EU word mark XENASA — Earlier EU word mark PENTASA — Relative ground for refusal — No likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001))
 ---documentbreak--- C2682018EN3210120180619EN0038321321Judgment of the General Court of 19 June 2018 — Tillotts Pharma v EUIPO — Ferring (XENASA)
   (Case T-362/16) (
         1
      )
   ‛(EU trade mark — Opposition proceedings — Application for EU word mark XENASA — Earlier EU word mark PENTASA — Relative ground for refusal — No likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001))’2018/C 268/38Language of the case: English
      Parties
   
   
      Applicant: Tillotts Pharma AG (Rheinfelden, Switzerland) (represented by: M. Douglas, lawyer)
   
      Defendant: European Union Intellectual Property Office (represented by: J. Ivanauskas and D. Walicka, acting as Agents)
   
      Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Ferring BV (Hoofddorp, Netherlands) (represented initially by: I. Fowler, Solicitor, and D. Slopek, lawyer, and subsequently by I. Fowler)
   
      Re:
   
   Action brought against the decision of the Fourth Board of Appeal of EUIPO of 29 April 2016 (Case R 3264/2014-4), relating to opposition proceedings between Ferring and Tillotts Pharma.
   
      Operative part of the judgment
   
   The Court:
   
            1.
         
         
            Annuls the decision of the Fourth Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 29 April 2016 (Case R 3264/2014-4);
         
      
            2.
         
         
            Orders EUIPO to bear its own costs and to pay those incurred by Tillotts Pharma AG;
         
      
            3.
         
         
            Orders Ferring BV to bear its own costs.
         
      (
         1
      )	OJ C 314, 29.8.2016.